Belite Bio stock soars 65% in wake of strong IPO performance
Belite Bio (BLTE) stock soared 65% on Tuesday on the heels of a strong performance last Friday following its $36M initial public offering
Source: seekingalpha.com
📰 Bio Seeks News
Bio Seeks News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bio Seeks. Real-time updates on events, politics, business and more.
Eye drug developer Belite Bio stock soars 160% following $36M IPO
Eye drug developer Belite Bio (BLTE) stock soared 160% following its $36M initial public offering. Shares of BLTE opened at $12.50 after pricing at $6 per American Depositary Share
United States Belite Bio Lin Bioscience Donovan Jones Belite Bio Antibiotics In Laboratory Research Scientist
Source: seekingalpha.com